1453-1462 IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome

Journal of Clinical Oncology

Volumn 32, Issue 14, 2014, Pages 1453-1462

  Russell, Lisa J ^a   Enshaei, Amir ^a   Jones, Lisa ^a   Erhorn, Amy ^a   Masic, Dino ^a   Bentley, Helen ^a   Laczko, Karl S ^b   Fielding, Adele K ^c   Goldstone, Anthony H ^d   Goulden, Nicholas ^e   Mitchell, Christopher D ^f   Wade, Rachel ^g   Vora, Ajay ^h   Moorman, Anthony V ^a   Harrison, Christine J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Leica Microsystems Lithography Ltd   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADOLESCENT DISEASE; ADULT; ADULT DISEASE; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE TRANSLOCATION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; OUTCOME ASSESSMENT; PHILADELPHIA CHROMOSOME NEGATIVE CELL; PRE B LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; YOUNG ADULT; CLINICAL TRIAL (TOPIC); GENETICS; INFANT; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIPLEX POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 84902980183     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.51.3242     Document Type: Article

References (33)

1. Moorman AV: The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia. Blood Rev 26:123-135, 2012
2. Molyneux EM, Rochford R, Griffin B, et al: Burkitt's lymphoma. Lancet 379:1234-1244, 2012
3. Freedman A: Follicular lymphoma: 2012 update on diagnosis and management. Am J Hematol 87:988-995, 2012
4. Chapiro E, Russell L, Radford-Weiss I, et al: Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia. Blood 108:3560-3563, 2006
5. Akasaka T, Balasas T, Russell LJ, et al: Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 109:3451-3461, 2007 (Pubitemid 46572535)
6. Russell LJ, Akasaka T, Majid A, et al: t(6; 14)(p22;q32): A new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 111:387-391, 2008
7. Russell LJ, De Castro DG, Griffiths M, et al: A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin. Leukemia 23:614-617, 2008
8. Russell LJ, Capasso M, Vater I, et al: Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood 114:2688-2698, 2009
9. Willis TG, Zalcberg IR, Coignet LJ, et al: Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21. Blood 91:1873-1881, 1998 (Pubitemid 28185487)
10. Aventín A, Sánchez J, Nomdedéu JF, et al: Novel IGHalpha translocations, t(2;14)(q14.3;q32) and t(14;17)(q32;q21), in B-cell precursor acute lymphoblastic leukemia. Cancer Genet Cytogenet 185:57-59, 2008 (Pubitemid 352014898)
11. Pegoraro L, Palumbo A, Erikson J, et al: A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc Natl Acad Sci U S A 81:7166-7170, 1984 (Pubitemid 15216717)
12. Chapiro E, Russell LJ, Struski S, et al: A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia. Leukemia 24:1362-1364, 2010
13. Moorman AV, Schwab C, Ensor HM, et al: IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia. J Clin Oncol 30:3100-3108, 2012
14. van der Velden VH, Cazzaniga G, Schrauder A, et al: Analysis of minimal residual disease by Ig/TCR gene rearrangements: Guidelines for interpretation of real-time quantitative PCR data. Leukemia 21:604-611, 2007 (Pubitemid 46444541)
15. Schwab CJ, Jones LR, Morrison H, et al: Evaluation of multiplex ligation-dependent probe amplification as a method for the detection of copy number abnormalities in B-cell precursor acute lymphoblastic leukemia. Genes Chromosomes Cancer 49:1104-1113, 2010
16. Gale KB, Ford AM, Repp R, et al: Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci U S A 94:13950-13954, 1997 (Pubitemid 28009690)
17. Wiemels JL, Ford AM, Van Wering ER, et al: Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Blood 94:1057-1062, 1999 (Pubitemid 29361838)
18. Maia AT, van der Velden VH, Harrison CJ, et al: Prenatal origin of hyperdiploid acute lymphoblastic leukemia in identical twins. Leukemia 17:2202-2206, 2003 (Pubitemid 37428387)
19. Morton LM, Wang SS, Devesa SS, et al: Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107:265-276, 2006 (Pubitemid 43053551)
20. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al: Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 41:1006-1010, 2009
21. Treviño LR, Yang W, French D, et al: Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 41:1001-1005, 2009
22. Roberts KG, Morin RD, Zhang J, et al: Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell 22:153-166, 2012
23. Hunger SP, Loh ML, Whitlock JA, et al: Children's Oncology Group's 2013 blueprint for research: Acute lymphoblastic leukemia. Pediatr Blood Cancer 60:957-963, 2013
24. Harvey RC, Mullighan CG, Chen IM, et al: Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood 115:5312-5321, 2010
25. Harvey RC, Mullighan CG, Wang X, et al: Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: Correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood 116:4874-4884, 2010
26. Chen IM, Harvey RC, Mullighan CG, et al: Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: A Children's Oncology Group study. Blood 119:3512-3522, 2012
27. Ensor HM, Schwab C, Russell LJ, et al: Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: Results from the MRC ALL97 clinical trial. Blood 117:2129-2136, 2011
28. Schwab CJ, Chilton L, Morrison H, et al: Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: Association with cytogenetics and clinical features. Haematologica 98:1081-1088, 2013
29. Inthal A, Krapf G, Beck D, et al: Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia. Clin Cancer Res 14:7196-7204, 2008
30. Pabst T, Mueller BU, Zhang P, et al: Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 27:263-270, 2001 (Pubitemid 32201846)
31. Pabst T, Mueller BU, Harakawa N, et al: AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia. Nat Med 7:444-451, 2001 (Pubitemid 32298547)
32. Yoda A, Yoda Y, Chiaretti S, et al: Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A 107:252-257, 2010
33. Weigert O, Lane AA, Bird L, et al: Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition. J Exp Med 209:259-273, 2012